The $113.7M modification adds to Leidos's backlog and confirms a strong relationship with HHS/NCI. Traders should monitor for additional task orders under this IDIQ vehicle and any future earnings calls that may provide updated revenue guidance reflecting this award.
Price Chart
Executive Summary
Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings (LDOS), received a $113.7M modification to its NCI operational task order from the Department of Health and Human Services. This is a material contract action for a key federal customer, reinforcing Leidos's position in health IT and biomedical research services.
Key Financial Metrics
Key Facts
- Leidos Biomedical Research Inc. received a $113.7M modification (P00011) to contract 75N91025F00016 from the Department of Health and Human Services.
- The modification is for the NCI Operational Task Order, covering FY26-FY27.
- Action date is 2026-08-31.
- The award is a modification to an existing contract, indicating ongoing work and a strong agency relationship.
- Leidos's annual revenue is not available in the provided data, so revenue impact percentage cannot be calculated.
Financial Impact
$113.7M contract modification from HHS for NCI operational task order.
Risk Factors
- Government funding risk from continuing resolutions or budget sequestration.
- Execution risk on the operational task order.
- Political/regulatory risk from changes in HHS or NCI priorities.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| GOVT-CONTRACT Data (Synthetic) | contract-75N91025F00016 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 17d ago | Press Release | $129.24 $123.31 | ▼ −4.59% | ▼ −6.72% | $119.07 (−7.87%) |
Sep 9, 2026 23d ago | GOVT-CONTRACT | $128.14 $129.35 | ▲ +0.94% | ▲ +1.60% | $119.07 (−7.08%) |
Aug 31, 2026 4w ago | GOVT-CONTRACT | $140.21 $129.24 | ▼ −7.82% | ▼ −7.68% | $119.07 (−15.08%) |
Aug 31, 2026 4w ago | GOVT-CONTRACT | $140.21 $129.24 | ▼ −7.82% | ▼ −7.68% | $119.07 (−15.08%) |
Aug 31, 2026 4w ago | GOVT-CONTRACT | $140.21 $129.24 | ▼ −7.82% | ▼ −7.68% | $119.07 (−15.08%) |
Aug 25, 2026 5w ago | Press Release | $134.54 $139.18 | ▲ +3.45% | ▲ +3.99% | $119.07 (−11.50%) |
Aug 12, 2026 7w ago | Institutional Cluster | $140.38 $146.31 | ▲ +4.22% | ▲ +4.67% | $119.07 (−15.18%) |
Aug 11, 2026 7w ago | 144 | $140.66 $143.37 | ▲ +1.93% | ▲ +2.33% | $119.07 (−15.35%) |
Aug 3, 2026 8w ago | Press Release | $118.72 $139.10 | ▲ +17.17% | ▲ +15.14% | $119.07 (+0.29%) |
Aug 3, 2026 8w ago | GOVT-CONTRACT | $118.72 $139.10 | ▲ +17.17% | ▲ +15.14% | $119.07 (+0.29%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access